The price, and that is confidential and was negotiated for all in all , 300 huge number of doses, is slightly less than the $19.50 per photo the United States agreed to buy a very first shipment of hundred million doses of the identical vaccine, in series with what Reuters claimed in November.
The EU file dated Nov. 18 was circulated internally following the EU announced the supply deal of its with Pfizer and its German partner BioNTech on Nov. 11.
The EU drug regulator is actually expected to decide on Monday on endorsement for the Pfizer vaccine following the shot was authorised in a number of countries, including Britain and the United States.
On Thursday Belgian say secretary with the spending budget Eva De Bleeker released on Twitter a dinner table with price tags Belgium will spend pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the post shortly after posting.
In this dinner table the Pfizer vaccine was indicated as costing Belgium 12 euros ($14.6) a dose, leading many to think that was the full fee agreed by way of the EU.
Various other vaccines in the family table were additionally shown with rates lower than prices disclosed by EU solutions.
“There is for sure a complete price along with a price upon delivery,” an EU official required in talks with vaccine makers told Reuters when directed to clarify the difference between the EU and Belgian rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament last week. In that public hearing, De Beeker said Belgium’s budgeted costs were still partial.
Underneath EU prior purchase deals for COVID 19 vaccines, the bloc agrees initial payments with companies to secure doses before they’re approved. Following approvals, EU governments are able to pay the remainder to buy reserved doses.
The EU has not revealed the initial payment agreed with Pfizer.
But, it stated in October which it paid aproximatelly 1 billion euros in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for their shots, with a further 1.45 billion euros budgeted for upfront payments to Pfizer BioNTech, Moderna and Curevac.
It has since agreed source deals with all 6 businesses and is negotiating a seventh arrangement with Novavax.